The aim of the study was to examine in the obese Zucker (fa/fa) rats the effect of a peroxisome proliferator
nafenopin on liver and brown adipose tissue peroxisomal and mitochondrial beta-oxidation
enzyme activities and on the overall energy dissipation. A 17-day
nafenopin treatment increased liver wet weight 2.1-fold and liver total
acyl-CoA oxidase and mitochondria beta-oxidative activities 32- and 4.6-fold, respectively. It increased the interscapular brown adipose tissue (IBAT)
acyl-CoA oxidase activity 2.1-fold but had no effect on the mitochondria beta-oxidative activity. Because
nafenopin was found to decrease food intake by 22%, obese
nafenopin-treated rats were compared with a group of obese pair-fed rats. Both food restriction and
nafenopin treatment decreased
body weight gain, but a decrease (14%) in fat content was only observed in
nafenopin-treated rats. Food restriction of obese rats decreased the mean metabolic rate by 13%, and
nafenopin treatment prevented this decrease. Both food restriction and
nafenopin treatment decreased the mean daily respiratory quotient (RQ). However, the RQ of
nafenopin-treated rats was steadily lower than that of control, whereas that of food-restricted rats was the same as that of control animals during the feeding period and decreased when food supply was exhausted. The increase in liver and IBAT
fatty acid beta-oxidative activities may be the cause of the decreased
lipid accretion measured in obese rats.